Intra-Operative Positioning System (IOPS) (MC-1) +7 more— 510(k) K261329
Substantially EquivalentCenterline Biomedical
FDA 510(k) clearance K261329 for Intra-Operative Positioning System (IOPS) (MC-1) +7 more, Substantially Equivalent on 2026-06-10. Applicant: Centerline Biomedical. Device class: 2.
Summary
Centerline Biomedical's clearance covers the Intra-Operative Positioning System (IOPS, MC-1) and seven other IOPS items: four Viewpoint catheters (Simple Curve and Double Curve, each in 75cm and 125cm), Guidewire 2 (ATW-2), a Fiducial Tracking Pad (T02111), and a Guidewire Handle (H01035). They're filed under DQK, programmable diagnostic computers.
Class II, 21 CFR 870.1425. Cardiovascular is both the classification panel and the review panel. It came in as a Special 510(k).
Centerline filed from Warrensville Heights, Ohio. The decision came 49 calendar days after receipt (April 22 to June 10, 2026).
Clearance details
- Device name as filed
- Intra-Operative Positioning System (IOPS) (MC-1);IOPS Viewpoint Simple Curve Catheter, 75cm (C00751);IOPS Viewpoint Simple Curve Catheter, 125cm (C01251);IOPS Viewpoint Double Curve Catheter, 75cm (C00752);IOPS Viewpoint Double Curve Catheter, 125cm (C02152);IOPS Guidewire 2 (ATW-2);IOPS Fiducial Tracking Pad (T02111);IOPS Guidewire Handle (H01035)
- Applicant
- Centerline Biomedical
- Product code
- Product code DQK
- Device class
- Class 2
- Regulation
- 21 CFR 870.1425
- Advisory panel
- Cardiovascular
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Special
- Location
- Warrensville Heights, OH, US
Recent devices under product code DQK
view allAdverse events under product code DQK
product code DQK- Death
- 10
- Injury
- 225
- Malfunction
- 2,123
- Other
- 2
- Total
- 2,360
Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →
Data sourced from openFDA. This site is unofficial and independent of the FDA.